Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
REMEDY.HE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q4.22
N/A
0.11
vs NA
Q1.23
N/A
-0.31
vs -0.02
Q2.23
N/A
-0.20
vs -0.19
Q3.23
N/A
-0.53
vs -0.04
Q4.23
N/A
-1.06
vs 0.11
Q1.24
N/A
-0.16
vs -0.31
Q2.24
N/A
-0.16
vs -0.20
Q4.24
N/A
-0.09
vs -1.06
Q1.25
+126%
0.04
vs -0.16
Q2.25
+194%
0.15
vs -0.16
Sales Growth
YoY
Current
Estimates
Q4.22
-31%
13.6M vs 19.8M
Q1.23
-28%
7.9M vs 11M
Q2.23
-5%
8.9M vs 9.4M
Q3.23
-16%
9.1M vs 10.8M
Q4.23
+33%
18.1M vs 13.6M
Q1.24
+34%
10.6M vs 7.9M
Q2.24
+16%
10.3M vs 8.9M
Q4.24
-36%
11.7M vs 18.1M
Q1.25
+27%
13.4M vs 10.6M
Q2.25
+65%
17.1M vs 10.3M
Return on Equity
QoQ
Q1.23
-5%
-0.05
vs 0.02
Q2.23
-3%
-0.03
vs -0.05
Q3.23
-11%
-0.11
vs -0.03
Q4.23
-21%
-0.21
vs -0.11
Q1.24
-3%
-0.03
vs -0.21
Q2.24
-3%
-0.03
vs -0.03
Q4.24
-2%
-0.02
vs -0.03
Q1.25
+1%
0.01
vs -0.02
Institutionnal Ownership
Quote Panel
Key Metrics
Relative Strength
REMEDY.HE
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How REMEDY.HE compares to sector?